Skip to content

Soft Tissue Volume Gain and Stability Comparing Palate and Tuberosity

Clinical and Histological Analysis of Soft Tissue Volume Gain and Stability Around Dental Implants Using Autogenous Subepithelial Connective Tissue Grafts Harvested From the Palate or Tuberosity. A Randomized Controlled Clinical Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03090906
Enrollment
32
Registered
2017-03-27
Start date
2015-04-30
Completion date
2017-08-31
Last updated
2017-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recession, Gingival, Tooth Loss

Keywords

volume gain, soft tissue augmentation, dental implants, histology

Brief summary

The goal of this study is to compare clinical and histologically the soft tissue changes in terms of volume gain and stability around dental implants in cases where a subepithelial connective tissue graft from the palate or from the tuberosity is used randomly

Detailed description

Understanding the importance of the soft tissue around implants have lead clinicians to develop surgical approaches to augment it. The majority of them, are described as bilaminar techniques obtaining a subephitelial connective tissue graft (SCTG) from the palate (P). However, recent studies have demonstrated that tuberosity (T) tissue is a very dense and coarse tissue that seems to contain more collagen and less fat and glandular tissue than that from the P, and therefore may have better tissue qualities for soft tissue augmentation, but there is limited scientific evidence comparing these areas. The main goal of this study is to compare the soft tissue volume gain and stability around implants in cases where a SCTG of the same dimensions from the P or T is used randomly. To calculate volume changes and stability an intraoral optical scan is used and three-dimensional images superimposed. The secondary goal is to compare histologically both tissues and changes in clinical parameters. Histomorphometry and immunohistochemistry evaluating levels of Type I-III collagen, long lysyl hydroxylase, matrix metalloproteinase 1-2, and monoclonal antibody against cytokeratin 4-10-13 is performed.

Interventions

PROCEDURESoft tissue augmentation palate

Recipient site: Intrasulcular incision at the buccal side of the implant extending in one adjacent tooth for each side and a partial-thickness mucosal flap raised. The connective tissue was secured with suture. Allocation to either treatment was performed according to a randomization table. Donor site A double-bladed scalpel handle 1,5mm was used in both areas to obtain the same thickness. Palate (CG) The double incision was made approximately 2 to 3 mm apical to the gingival margins of premolars. The donor tissue was removed and cross-mattress sutures were used to approximate the wound on the palate. In both groups the epithelial collar removed. Graft required dimensions for both groups:10mm height, 12mm length and 1,5mm thick.

PROCEDURESoft tissue augmentation tuberosity

Recipient site: Intrasulcular incision at the buccal side of the implant extending in one adjacent tooth for each side and a partial-thickness mucosal flap raised. The connective tissue was secured with suture. Allocation to either treatment was performed according to a randomization table. Donor site A double-bladed scalpel handle 1,5mm was used in both areas to obtain the same thickness. Tuberosity (TG) The double incision was made from the distal of the terminal tooth. A second incision was made perpendicular to the linear incision at a distal point, which joined the two linear incisions. The graft was removed and a crossed horizontal suspension suture was used. Epithelial collar removed. Graft required dimensions for both groups:10mm height, 12mm length and 1,5mm thick.

DEVICEIntraoral optical scan

Intraoral optical scan was performed at both groups at baseline, 3 months, 4 months and 12 months to be able to compare volumetric changes.

Sponsors

Osteology Foundation
CollaboratorOTHER
Universitat Internacional de Catalunya
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patient must be ≥18 years and able to understand the nature of the proposed surgery and to a signed informed consent. * Implant must be located between 2 fixed reference points i.e. clinical crowns. * All implants locations with a need of a soft tissue volume augmentation. * Palate must have ≥2mm of thickness at premolar area. * Tuberosity \> 12mm in length. * Full mouth plaque and bleeding score \<20%.

Exclusion criteria

* Previous soft tissue augmentation in the area. * Heavy Smokers (\> 10 cigarettes per day). * Local or systemic conditions that would interfere with routine periodontal therapy (non controlled diabetes, liver function disorder, immunosuppressant disease, autoimmune disease). * Allergy to Non-Steroidal Anti-Inflammatory Drugs. * Patients taking medications that cause gingival enlargement * Gingival idiopatic overgrowth

Design outcomes

Primary

MeasureTime frameDescription
Soft tissue volume gainBaseline to 3 months postoperativeFollowing soft tissue augmentation procedure volume gain is registered using intraoral optical scan. Superposition between three dimensional images from baseline (before augmentation procedure) and 3 months postoperative is done.
Soft tissue stability4 months postoperative to 12 months postoperativeTo evaluate soft tissue stability an intraoral optical scan is performed at 4 and 12 months postoperative. Also a superimposition between 4 months and 12 months optical images is done.

Secondary

MeasureTime frameDescription
HistologyBaselineDescriptive histology and immunohistochemistry evaluating: Type I-III collagen, long lysyl hydroxylase, matrix metalloproteinase 1-2, and monoclonal antibody against cytokeratin 4-10-13.
Clinical periodontal parameters Plaque Index and Bleeding on probingBaseline, 3 months, 4 months, 12 monthsPlaque index, bleeding on probing expressed as a full mouth %.
Clinical periodontal parameters.Probing depthBaseline, 3 months, 4 months, 12 monthsProbing depth expressed in mm. Evaluated at implant and adjacent teeth. At Mesial, distal, buccal, lingual, mesiobuccal, mesiolingual, distobuccal and distolingual levels.
Clinical periodontal parameters. Width of keratinized tissueBaseline, 3 months, 4 months, 12 monthsWidth of keratinized tissue expressed in mm, evaluated at medial point at implant and adjacent teeth one.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026